![Yu Ling Luo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yu Ling Luo
Chief Executive Officer at
ALAMAR BIOSCIENCES, INC.
Net worth: 86 M $ as of 2026-06-29
Profile
Yu Ling Luo was the founder of Advanced Cell Diagnostics, Inc., founded in 2006, serving as President, Chief Executive Officer & Director.
Dr. Luo is the founder of Alamar Biosciences, Inc., founded in 2018, holding the title of Chairman & Chief Executive Officer.
Dr. Luo is the founder of Alamar Biosciences, Inc. (California), founded in 2018, holding the title of Chairman & Chief Executive Officer.
Dr. Luo is also the founder of Panomics LLC..
Dr. Luo is currently a Venture Partner at IIF Management Co. LLC since 2020.
Former positions include Scientist at Exelixis, Inc. and President at Bionostics, Inc. from 2016 to 2018.
Education includes a doctorate from Case Western Reserve University and an undergraduate degree from the University of Science & Technology of China.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 3,164,726 ( 4.57% ) | 86 M $ | 2026-06-29 |
Yu Ling Luo active positions
| Companies | Position | Start |
|---|---|---|
| ALAMAR BIOSCIENCES, INC. | Chief Executive Officer | 2018-06-30 |
IIF Management Co. LLC
 IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 2019-12-31 |
Former positions of Yu Ling Luo
| Companies | Position | End |
|---|---|---|
Bio-Techne
 Bio-Techne Medical SpecialtiesHealth Technology Provides liquid quality control standards used to confirm the performance of medical testing devices | Private Equity Investor | 2018-01-31 |
Alamar Biosciences, Inc.
 Alamar Biosciences, Inc. Medical SpecialtiesHealth Technology In vitro diagnostics | Chief Executive Officer | - |
Panomics LLC
 Panomics LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences research reagents | Founder | - |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
Advanced Cell Diagnostics, Inc.
 Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Develops cell and tissue based diagnostic tests | Founder | - |
Training of Yu Ling Luo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
27
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences research reagents | Commercial Services |
Alamar Biosciences, Inc.
Alamar Biosciences, Inc. Medical SpecialtiesHealth Technology In vitro diagnostics | Health Technology |
Bio-Techne
Bio-Techne Medical SpecialtiesHealth Technology Provides liquid quality control standards used to confirm the performance of medical testing devices | Health Technology |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Cell Diagnostics, Inc.
Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Develops cell and tissue based diagnostic tests | Health Technology |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance Illumina Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of life science tools, diagnostics, therapeutics, digital health and sustainability sectors. It provides financing for early stage capital requirements. | Finance |
Alamar Biosciences, Inc. (California)
 Alamar Biosciences, Inc. (California) BiotechnologyHealth Technology Develops a proteomic liquid biopsy platform and sells instruments, consumables & services for the early detection of diseases | Health Technology |
- Stock Market
- Insiders
- Yu Ling Luo
